![](https://canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBY3c9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--d2a5b8d0f05954a43ded6c06a94ee7c42f781c5b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/matrix_pharmaceutical_68093.jpg)
Matrix Pharmaceutical
Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.
Investment
Series A
Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.
Series A